FDA OKs Hologic's 3-D breast imaging system

by Olga Deshchenko, DOTmed News Reporter | February 11, 2011

Hologic's tomosynthesis system is already on the market in more than 40 countries across the world. In North America, units have already been installed in Mexico and Canada, according to the company.

"We are extremely proud to be the first company to receive FDA approval of a 3-D digital mammography system and to offer women this ground-breaking, superior imaging technology," Rob Cascella, Hologic's president and CEO, said in prepared remarks. "Our Dimensions 3-D takes advantage of all of the benefits of digital mammography and quite simply makes it better with the combination of fast, high quality 3-D breast imaging."

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.

Nearly 200,000 women will be diagnosed with breast cancer this year, according to the National Cancer Institute. If the cancer is detected early and still localized to the breast, the survival rate is 98 percent.

"We believe tomosynthesis has the potential to change how screening and diagnostic mammography is performed, and over time will prove invaluable to the earliest possible detection of breast cancer and in the reduction of unnecessary diagnostic interventions," said Cascella.

Back to HCB News